Association of high-dose radioactive iodine therapy with PPM1D-mutated clonal hematopoiesis in older individuals.
Saved in:
| Title: | Association of high-dose radioactive iodine therapy with PPM1D-mutated clonal hematopoiesis in older individuals. |
|---|---|
| Authors: | Kim J; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Korea.; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea.; Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Bae S; Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea., Choi J; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Korea.; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea.; Department of Biochemistry and Molecular Biology, Kangwon National University School of Medicine, Gangwon, Korea., Im SW; Department of Biochemistry and Molecular Biology, Kangwon National University School of Medicine, Gangwon, Korea., Cha B; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Korea.; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea., Jung G; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea., Cho SW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea., Seo EJ; Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Lee YA; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Korea.; Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea., Paeng JC; Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Korea., Park YJ; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Korea.; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea., Kim JI; Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Korea.; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea. |
| Source: | Molecular oncology [Mol Oncol] 2025 Nov; Vol. 19 (11), pp. 3079-3095. Date of Electronic Publication: 2025 Jun 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1878-0261 |
|---|---|
| DOI: | 10.1002/1878-0261.70078 |
